{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:01:39Z","timestamp":1793246499272,"version":"4.5.0"},"reference-count":42,"publisher":"American Chemical Society (ACS)","issue":"1","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2024,1,1]]},"DOI":"10.1021\/acs.molpharmaceut.3c01059","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T14:19:41Z","timestamp":1702649981000},"page":"358-369","source":"Crossref","is-referenced-by-count":15,"title":["Quabodepistat (OPC-167832), a Novel Antituberculosis Drug Candidate: Enhancing Oral Bioavailability via Cocrystallization and Mechanistic Analysis of Bioavailability in Two Cocrystals"],"prefix":"10.1021","volume":"21","author":[{"given":"Nasa","family":"Sakamoto","sequence":"first","affiliation":[{"name":"Preformulation Research Laboratory, CMC Headquarters, Otsuka Pharmaceutical Co., Ltd., Tokushima 771-0182, Japan"},{"name":"Department of Molecular Pharmaceutics, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Miyata","sequence":"additional","affiliation":[{"name":"Preformulation Research Laboratory, CMC Headquarters, Otsuka Pharmaceutical Co., Ltd., Tokushima 771-0182, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9042-8646","authenticated-orcid":true,"given":"Toshiro","family":"Fukami","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmaceutics, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2020.100075"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13101682"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1021\/mp0600182"},{"issue":"2","key":"ref4\/cit4","first-page":"220","volume":"2","author":"Sharma D.","year":"2009","journal-title":"Res. J. Pharm. Technol."},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2020.1716876"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13071034"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/820653"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1021\/mp200460u"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.7b00275"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1021\/acs.cgd.7b01096"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2005.03.016"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b19-00048"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2020.108649"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2005.11.013"},{"key":"ref15\/cit15","unstructured":"U.S.\nFood and Drug Administration. Guidance for Industry, Regulatory Classification\nof Pharmaceutical Co-Crystals. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/regulatory-classification-pharmaceutical-co-crystals (accessed February 19, 2023)."},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2012.07.038"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1039\/b715396a"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.3390\/cryst10030211"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jpca.0c09536"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1021\/acs.cgd.0c01043"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1021\/acs.cgd.0c01153"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105422"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1021\/cg801039j"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1021\/acs.cgd.7b01206"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1021\/cg9001187"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1021\/acs.cgd.8b00362"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1021\/acs.cgd.9b01026"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.9b00501"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-010-0213-8"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1021\/mp400465p"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.1c00537"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02020-19"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-014-1296-4"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1107\/S2053273314026370"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1107\/S2053229614024218"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2017.08.006"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1107\/S2056989023006047"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2018.10.108"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1021\/ie071452o"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.40.3303"},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(96)04524-3"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1021\/acs.cgd.6b01425"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.3c01059","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.3c01059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T09:09:47Z","timestamp":1704100187000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.3c01059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,1]]}},"alternative-id":["10.1021\/acs.molpharmaceut.3c01059"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c01059","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]}}}